In addition, four targets (ACACA, MAOB, CAT, CA2) were the intersection of potential HS targets and potential biomarker targets, indicating that these four targets might be the most relevant targets for the treatment of T2DM with HS. This evidence concerns the gene CAT and type 2 diabetes mellitus.